GFAP and depressive symptom measurement: Similarly, there was no difference in the density of GFAP-positive astrocyte protein in any of the hippocampal regions between patients with and without depressive suicide, whereas the fraction of GFAP immunoreactivity in the CA2/3 area was inversely correlated with the duration of depression in suicide victims [43].